Testicular cancer accounts for a small percentage of cancer diagnoses in the U.S., with fewer than 10,000 new cases (around 1 of every 250 males) each year. Although uncommon, it’s the most frequently diagnosed cancer in males between 15 and 35. The disease typically begins in the germ cells responsible for producing sperm.
Complex medical terminology, diagnostic methods, and treatment strategies can confuse and overwhelm anyone, especially patients who want to know everything about their diagnosis but are unacquainted with oncological care. Knowing what questions to ask can cut through medical jargon.
Before Anything Else, Request Simpler Language During Appointments
Many patients find medical vocabulary unfamiliar and difficult to apply to their case, more so when hearing such terms for the first time and during a stressful moment.
Requesting explanations in everyday terms does not reduce the seriousness of a diagnosis. Instead, it removes barriers that delay action. A patient who does not understand what the doctor said may hesitate to ask the next question or postpone a decision.
Testicular cancer has terms like germ cell, seminoma, and embryonal carcinoma. No patient should hesitate or feel embarrassed to ask what those are. Physicians expect questions about wording, phrasing, and meaning, and they welcome the chance to clarify.
If a term is unfamiliar, patients should ask the doctor to explain it using different words rather than drawing conclusions. For example, a patient might say: “I heard what you said, but I don’t know what that term means. Can you explain it in another way?” This type of question steers the conversation toward information the patient can use when weighing treatment or managing side effects.
Frequently Asked Questions About Testicular Cancer
Asking the following questions may help patients learn more about testicular cancer and what to expect next.
1. How Do You Know I Have Testicular Cancer?
Diagnosing testicular cancer starts with a doctor examining the scrotum, the sac of skin holding and protecting the testicles. During this physical exam, they’ll check for size, shape, and texture changes. A firm or irregular mass raises suspicion of malignancy (cancer). Following up with a scrotal ultrasound will help identify whether a mass contains solid tissue and whether it arises within the testicle. Solid intratesticular masses strongly suggest cancer, while cysts, fluid collections, or structures outside the testicle may indicate a different condition.
Physicians also use blood tests to measure tumor markers, which are substances in the body that signal the presence or activity of cancer. These markers include alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH). Certain tumors release these markers into the bloodstream. Elevated levels help determine tumor type and support the diagnosis. Some tumors do not alter these values, so doctors interpret results in context with other findings.
Doctors then use computed tomography (CT) to examine the abdomen, pelvis, and chest. These scans detect lymph node involvement or metastatic spread to the lungs.
If results strongly suggest cancer, an inguinal orchiectomy to remove the affected testicle may be necessary. Urologists perform this procedure through an incision above the groin. They resort to this approach to limit the risk of tumor cells metastasizing (spreading) and to confirm the diagnosis. A pathologist then examines the removed tissue and identifies the exact tumor type to guide the next step.
2. Could This Be Something Else?
Yes. Some conditions share symptoms with testicular cancer, including benign cysts, infections, or testicular torsion. All three can cause swelling, pain, or a mass. An accurate diagnosis requires imaging and blood tests. Sometimes, doctors cannot rule out cancer until they remove and examine the testicle through an inguinal orchiectomy.
3. What Type of Testicular Cancer Do I Have?
Most cases begin in the sperm-producing germ cells. The two main types are seminomas and non-seminomas.
Most seminomas grow at a slower pace, and they typically respond to treatment after surgery. Non-seminomas have several subtypes, such as yolk sac tumors, testicular choriocarcinoma, embryonal carcinoma, and teratoma. These tend to occur in younger men and may spread more quickly. The pathologist assigns the tumor type after removing and examining the testicle.
4. Why Do I Need to Know the Type?
Each type responds differently to treatment. Some respond to less invasive therapies, others do not. Treatment plans depend on the tumor type, its size, and whether cancer has reached other parts of the body.
5. What Stage Is My Cancer?
Doctors assign the stage of testicular cancer after reviewing surgical findings, tumor markers, and imaging results. Staging describes the extent of disease and identifies whether cancer has remained confined to the testicle or spread to other areas of the body.
Testicular cancer follows the TNM classification system:
- “T” depicts the size and extent of the primary tumor.
- “N” refers to lymph node involvement, usually in the retroperitoneal region.
- “M” indicates distant metastasis, such as spread to the lungs or other organs.
Tumor marker levels are also included in the staging criteria.
Unlike most cancers with four stages, testicular cancer only has three:
- Stage I indicates that cancer remains limited to the testicle. Imaging does not show any lymph nodes or distant involvement. Marker levels return to normal after orchiectomy or do not rise significantly at diagnosis.
- Stage II denotes metastasis to abdominal lymph nodes. Imaging shows enlarged retroperitoneal nodes, and marker levels may remain elevated after surgery.
- Stage III includes distant metastasis, often to the lungs, liver, or other organs. Tumor marker levels may remain elevated or continue to rise.
Doctors use the above classification by the American Joint Committee on Cancer to define the disease’s current extent and guide further treatment planning.
6. How Will the Stage Affect My Treatment?
Doctors recommend treatment based on the tumor type, marker behavior, and disease severity. Each stage corresponds to a different level of intervention. Let’s break these down in detail:
- In Stage I, treatment often begins and ends with orchiectomy. If marker levels normalize and imaging remains negative, patients may enter surveillance, which includes routine blood tests and imaging to detect early recurrence. In some cases, doctors recommend chemotherapy or radiation after surgery to lower the risk of relapse. Most patients are also eligible for precision oncology therapies that reduce treatment-related toxicity and help regulate immune recovery.
- In Stage II, treatment typically includes chemo or retroperitoneal lymph node dissection (RPLND) after inguinal orchiectomy. Treatment depends on tumor type and the size or appearance of the affected lymph nodes. Some cases require both surgery and systemic therapy. For patients seeking alternative therapies, they may undergo molecular profiling to guide targeted treatment. Precision oncology identifies mutations in tumors with atypical features or borderline marker behavior. Immunotherapy may manage residual disease in testicular cancer patients who cannot tolerate conventional regimens or who require lower-toxicity options.
- In Stage III, most doctors recommend systemic chemotherapy after orchiectomy. They base the chemotherapy regimen on tumor type and marker levels. Patients may require several cycles of treatment. If residual masses remain after chemotherapy, doctors may consider surgical removal. In select cases, molecular testing supports the use of targeted agents. Precision-matched drugs may minimize exposure to broad-spectrum chemotherapy, and immunotherapy may support long-term disease control in tumors with immunogenic properties.
Treatment planning always includes evaluation by a multidisciplinary team. Timing, dosage, and sequencing center on tumor biology, patient condition, and real-time response data. Facilities that use alternative or integrative approaches, like New Hope Unlimited, consider conventional guidelines and individual molecular profiles. Contact us if you have any questions. Our doctors would gladly answer them during a consultation.
7. How Long Will Treatment Last?
Treatment duration for testicular cancer varies by stage, histologic subtype, and the patient’s response to surgery and/or therapy. Orchiectomy is the beginning of the treatment process. Surgeons perform it as a same-day hospital procedure. Subsequent therapies depend on tumor markers, imaging results, and lymph node involvement.
Early-stage seminomas may require one or two cycles of carboplatin-based chemotherapy or a short course of radiotherapy, typically lasting two to three weeks. Early-stage non-seminomas often involve three cycles of bleomycin, etoposide, and cisplatin (BEP) administered over nine weeks.
For advanced disease, treatment may extend to four cycles of BEP over 12 weeks, or alternative regimens based on patient tolerance and tumor response. In some cases, post-chemotherapy retroperitoneal lymph node dissection may follow.
Precision oncology can shorten or modify treatment through molecular profiling. By identifying specific tumor characteristics, oncologists can determine whether standard chemotherapy is optimal or whether de-escalation, intensification, or novel agents are appropriate. This approach ensures that treatment corresponds to the tumor’s molecular characteristics, reducing unnecessary exposure and improving therapeutic efficacy.
Treatment ends when tumor markers normalize, imaging shows no disease, and no residual tumor remains. However, follow-up may last several years and includes periodic imaging, tumor marker surveillance, and clinical exams to detect recurrence.
8. Will I Need More Tests After Surgery and/or Treatment?
Likely. After surgery, doctors review blood marker levels again. If those levels fall, it suggests the tumor was the only active site. If levels stay high, the cancer may have spread. Doctors may order more scans to check for cancer in the lymph nodes, chest, or abdomen.
Bloodwork and imaging do not stop after the initial diagnosis. These tests help monitor recovery and catch signs of recurrence. Surveillance continues for several years.
9. Can I Still Have Sex After Testicular Cancer Treatment?
Yes. Most patients maintain normal sexual function after removal of one testicle. The unaffected testicle produces testosterone and supports sperm development in a large number of cases. Erectile response, sexual interest, and orgasmic capacity proceed without disruption unless treatment-related factors affect them. Some treatment options, however, may influence these outcomes through hormonal shifts or nerve-related changes:
- RPLND may affect ejaculation. This surgical procedure can alter the nerves responsible for directing semen outward during climax. As a result, semen may travel into the bladder instead of exiting through the urethra. This condition is called retrograde ejaculation. It does not cause physical harm, but it prevents natural conception through intercourse.
- Chemotherapy may temporarily affect testosterone levels or sperm quality. Some drugs damage the cells involved in sperm development. Testosterone usually returns to baseline levels within months, but recovery timelines vary. Doctors may assess hormone levels during follow-up if symptoms such as fatigue, reduced libido, or mood changes arise.
- Psychological factors also affect sexual health. Changes in body image, performance anxiety, or fear of recurrence may contribute to sexual dysfunction. These concerns do not always stem from physical causes. Referral to a specialist may help address these symptoms. Further reading: Mental Health of Testicular Cancer Patients
10. Will My Body Look Different After Surgery?
Slightly. The empty sac may cause the scrotum to hang unevenly or appear deflated on one side, especially when standing or unclothed. Some patients request a testicular prosthesis to restore symmetry. The implant resembles the size and weight of a testicle but does not have a medical function. Surgeons can place it during the initial procedure or at a later time.
11. Can Testicular Cancer Treatment Affect Fertility?
Some treatment options interfere with fertility, either temporarily or permanently. For instance, chemotherapy and radiation may damage the cells that produce sperm. The degree of damage depends on the drugs used, the number of treatment cycles, and the patient’s baseline fertility. In some patients, sperm production recovers within one to two years. In others, recovery does not occur.
Orchiectomy alone rarely causes infertility. As mentioned, the remaining testicle may continue to produce sperm. However, fertility varies from person to person. Many patients with testicular cancer already have low sperm count at diagnosis.
Doctors often recommend sperm banking before starting treatment. This method collects and freezes semen samples to preserve or maximize the chances of fathering a child later. Fertility specialists can assist with this process, and collection may occur over several sessions. Stored samples remain viable for years under proper conditions.
12. Do I Need More Than One Doctor?
Testicular cancer may involve surgery, systemic therapy, radiation exposure, and, in some cases, long-term monitoring. Different physicians manage each phase based on disease behavior, clinical findings, and treatment requirements.
- The urologist examines the testicle, requests laboratory and imaging studies, and performs the orchiectomy. If pathology confirms cancer, the urologist reviews the surgical findings and tumor marker response to determine whether further surgery is necessary. In cases with confirmed retroperitoneal lymph node enlargement or incomplete marker decline, the urologist may recommend retroperitoneal lymph node dissection.
- The radiation oncologist treats patients with seminoma when imaging shows involvement of lymph nodes in the retroperitoneum. This form of therapy does not apply to non-seminomatous tumors.
- The medical oncologist manages chemotherapy, immunotherapy, and other treatments. Tumor type, disease extent, and marker levels determine whether these approaches are appropriate.
- The primary care physician oversees general health throughout oncology treatment and survivorship. This doctor manages ongoing medical needs such as routine screening, blood pressure regulation, metabolic conditions, and vaccination schedules while the cancer team addresses tumor-directed therapy. A primary care physician may also assist with medication management and referrals between specialists.
Additional specialists may include those in fertility medicine, endocrinology, or supportive care. These physicians address concerns related to sperm preservation, hormone levels, fatigue, or sexual health. Each case determines whether their involvement is necessary.
Patients undergoing treatment at multiple centers may request records or test results to maintain coordination across institutions. Communication between physicians supports continuity, especially when care transitions from oncology teams to primary care.
13. How Likely Am I to Survive Testicular Cancer?
Survival outcomes for testicular cancer exceed those of most other malignancies. Data from large population studies report five-year survival rates exceeding 95 percent for all stages combined. Nonetheless, prognosis varies based on tumor type, clinical stage at diagnosis, and response to treatment.
- Stage I testicular cancer has a five-year survival rate above 99%. In most cases, patients with localized tumors undergo orchiectomy followed by active surveillance or a short course of adjuvant therapy. Relapse during surveillance occurs in a minority of cases and usually responds well to subsequent treatment.
- Stage II disease includes patients with retroperitoneal lymph node involvement. Most receive systemic chemotherapy or retroperitoneal lymph node dissection following orchiectomy. Five-year survival rates for this group range from 90 to 95%, depending on tumor subtype and burden of nodal disease.
- Stage III disease includes patients with distant metastases. Treatment typically begins with multi-agent chemotherapy. Five-year survival rates in this group range from 70 to 80% based on tumor histology, extent of spread, and marker decline after treatment.
Survival estimates correspond to data collected from large cohorts. Individual outcomes may differ based on treatment tolerance, compliance with follow-up, and coexisting conditions. Physicians determine prognosis using staging systems, tumor marker kinetics, histologic features, and response to therapy over time.
14. Will My Cancer Come Back After Treatment?
Testicular cancer recurrence risk varies by tumor type, clinical stage, and treatment approach. Many patients live the rest of their lives without cancer returning, but when relapses occur, they happen within the first two years after orchiectomy. Patients under active surveillance without additional therapy have a higher risk of recurrence than those who receive adjuvant treatment, though most recurrences are curable. Long-term monitoring allows intervention at the earliest sign of relapse.
15. What Type of Follow-Up Will I Need After Treatment?
Follow-up includes physical examinations, tumor marker testing, and imaging at scheduled intervals. Blood tests monitor alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH), while CT scans assess lymph nodes and lungs for signs of recurrence. Follow-up visits occur every one to two months during the first year, then transition to quarterly, semiannual, and annual visits. Physicians adjust the schedule according to previous cancer stage, histology, and treatment response. Long-term care may also include hormonal evaluation and fertility assessment. Follow-up continues for several years under the same oncology team or transitions to primary care when appropriate.
In addition to these 15 questions, write down your own, too. You may wish to ask about clinical trials you qualify for, or whether non-surgical options are available for your case. And, aside from a doctor, other healthcare providers, such as social workers and nurses, may have the answers to your questions. Don’t hesitate to involve them in discussions about your care.
Are You Looking for Alternative Treatments or Precision Medicine for Testicular Cancer?
Although testicular cancer has one of the highest cure and survival rates, it’s still a life-threatening disease without medical care. If you prefer a cross between conventional, alternative, and innovative cancer treatments, New Hope Unlimited has the personalized options you seek. Contact us now to begin planning your testicular cancer treatment.
